Chronic Glucocorticoid Exposure Potentiates Placental Chorionic Plate Artery Constriction: Implications for Aberrant Fetoplacental Vascular Resistance in Fetal Growth Restriction
The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
Fetal growth restriction (FGR) is a serious pregnancy complication, resulting in significant perinatal morbidity and mortality. Increased vascular resistance in the fetoplacental circulation is a hallmark of FGR and is associated with enhanced vasoconstriction of the resistance arteries in the placenta, the chorionic plate arteries (CPAs). Although the cause is unknown, FGR is associated with excess exposure to glucocorticoids (GCs), key mediators of vascular resistance in the systemic circulation. We hypothesized that GCs alter CPA reactivity, thereby contributing to the altered blood flow dynamics seen in FGR. We aimed to examine the acute and chronic effects of GCs on CPA reactivity and the operational mechanisms. Glucocorticoid receptors were highly expressed by CPA. 11β-Hydroxysteroid isoenzyme type 2 was detected within the endothelium, whereas 11β-hydroxysteroid isoenzyme type 1 was absent. Acute GC treatment significantly attenuated U46619-induced constriction. This effect was reversed by cotreatment with mifepristone or an endothelial NOS inhibitor. In contrast, chronic GC treatment potentiated U46619 constriction in a dose-dependent manner, which was partially abolished by mifepristone cotreatment. Similar effects were observed using a novel nonsteroidal glucocorticoid receptor-specific agonist. Chronic treatment with GCs altered the expression of several vasoactive factors, including thromboxane and bradykinin receptors, prokineticin-1, cyclooxygenase-2, and endothelial NOS. In summary, acute and chronic GC treatment exerts contrasting effects on CPA vasoreactivity. These opposing effects are consistent with temporal actions in other vascular beds and reflect activation of distinct nongenomic and genomic pathways. Chronic exposure to elevated GCs may contribute to the raised vascular resistance observed in the fetoplacental circulation in FGR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Human placental chorionic plate arteries abundantly express GC receptors; chronic GC exposure in vitro alters vasoreactivity, increasing vascular resistance and potentially contributing to hypertension (121).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [121]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basic and Clinical Pharmacology
Wingard, L. B. (1983) · Anesthesia & Analgesia · doi:10.1213/00000539-198308000-00015 · Cited by 630
Hafezi-Moghadam, A., Simoncini, T., Yang, Z., Limbourg, F. P., Plumier, J.-C., Rebsamen, M. C., Hsieh, C.-M., Chui, D.-S., Thomas, K. L., Prorock, A. J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-473 · Cited by 594
Fetal umbilical artery flow velocity waveforms and placental resistance: clinical significance
TRUDINGER, B. J., GILES, W. B., COOK, C. M., BOMBARDIERI, J., & COLLINS, L. (1985) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1985.tb01044.x · Cited by 561 · cited 1×
“In pregnancies complicated by FGR, Doppler waveform analyses of umbilical arteries identify an increase in resistance to blood flow in the fetoplacental circulation (5-7), indicating abnormal delivery of oxygen and nutrients to the fetus.”
BackgroundPlacental 11β‐hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure
Benediktsson, R., Calder, A. A., Edwards, C. R. W., & Seckl, J. R. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1230939.x · Cited by 536
Glucocorticoids and Vascular Reactivity
Yang, S., & Zhang, L. (2004) · Current Vascular Pharmacology · doi:10.2174/1570161043476483 · Cited by 308 · cited 1×
“Glucocorticoids (GCs) have well-documented actions in the regulation of systemic vascular reactivity, both via genomic and nongenomic pathways (11).”
BackgroundWallerath, T., Witte, K., Schäfer, S. C., Schwarz, P. M., Prellwitz, W., Wohlfart, P., Kleinert, H., Lehr, H.-A., Lemmer, B., & Förstermann, U. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13357 · Cited by 289 · cited 2×
“GCs are thought to modulate vascular tone through actions in both cell types: GCs inhibit vasodilator release (NO, prostacyclin) (34, 35) from endothelial cells and increase vasoconstrictive effects of catecholamines and angiotensin II by up-regulating 1B-adrenergic and AGTR1, respectively, in vascular smooth muscle c…”
BackgroundShams, M., Kilby, M. D., Somerset, D. A., Howie, A. J., Gupta, A., Wood, P. J., Afnan, M., & Stewart, P. M. (1998) · Human Reproduction · doi:10.1093/humrep/13.4.799 · Cited by 276
Li, M., Bullock, C. M., Knauer, D. J., Ehlert, F. J., & Zhou, Q. Y. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.692 · Cited by 269 · cited 1×
“Moreover, PROK1, a potent stimulator of smooth muscle constriction (38), is also enhanced, whereas AGRT1 was unaffected.”
BackgroundDevelopmental Origins of Adult Disease
Langley-Evans, S. C., & McMullen, S. (2010) · Medical Principles and Practice · doi:10.1159/000273066 · Cited by 263
Fetal Programming and Metabolic Syndrome
Rinaudo, P., & Wang, E. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153245 · Cited by 250
Research works printed but not linked: 2
- Perinatal and Maternal Mortality Review Committee. Fifth Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting Mortality 2009. Health Quality and Safety Commission New Zealand, New Zealand; 2011.
- Chrousos GP. Adrenocorticoids and adrenocortical antagonists. In: Katzung BG, Masters SB, Trevor AJ, eds. Basic and Clinical Phar- macology. 10th ed. Columbus, OH: McGraw-Hill Medical; 2006: 635-652.
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Cortés, M. S., Carbajo, R. J., Crispi, F., Figueras, F., Pineda‐Lucena, A., & Gratacós, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080121 · Cited by 84
“transfer to the fetus has long been suggested as a potential pathogenic pathway of IUGR in humans [60,61].”
BackgroundPathogenesis of pregnancy complications in systemic lupus erythematosus
Østensen, M., & Clowse, M. E. B. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328363ebf7 · Cited by 72
“In a study [23] of placental resistance arteries, chronic treatment with glucocorticosteroids was found to potentiate vasoconstriction, thereby increasing the vascular resistance in the placenta.”
BackgroundSolano, M. E., Holmes, M. C., Mittelstadt, P. R., Chapman, K. E., & Tolosa, E. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0575-z · Cited by 67
“Similarly, chronic glucocorticoid over-exposure increases vascular resistance in the feto-placental circulation [97].”
BackgroundSafety issues of biologics in pregnant patients with rheumatic diseases
Østensen, M. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12456 · Cited by 53
He, B., Zhang, N., & Zhao, R. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25076 · Cited by 46
“Excessive exposure to GCs during pregnancy led to declined placental amino acid transport and retarded placental growth (Unek et al., 2012; Nugent et al., 2013).”
BackgroundFetal endocrine therapy for congenital adrenal hyperplasia should not be done
Miller, W. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.01.005 · Cited by 40
Chen, G., Xiao, H., Zhang, J., Zhang, H., Li, B., Jiang, T., Wen, Y., Jiang, Y., Fu, K., Xu, D., et al. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.09.007 · Cited by 27
Maternal pregnancy-related anxiety and children’s physical growth: the Ma’anshan birth cohort study
Zhou, J., Zhang, S., Teng, Y., Lu, J., Guo, Y., Yan, S., Tao, F., & Huang, K. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05711-5 · Cited by 31
“However, chronic exposure to elevated glucocorticoids (GCs) may contribute to increased vascular resistance observed in fetal placental circulation, which is a hallmark of fetal growth restriction [50].”
BackgroundFan, F.-Y., Shen, W.-T., Wu, S., Chen, N., Tong, X., Wang, F., & Zhang, Q. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.113976 · Cited by 17
Molecular and cellular underpinnings of normal and abnormal human placental blood flows
Li, Y., Lorca, R. A., & Su, E. J. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0139 · Cited by 17
“Chronic glucocorticoid treatment of chorionic plate arteries results in decreased PTGS2 expression and increases vascular resistance, although glucocorticoid treatment was shown to have effects on several other vasoactive mediators (Nugent et al. 2013).”
BackgroundTian, X., Zhao, J., Song, Y., Wang, Q., Li, M., Liu, J., & Zeng, X. (2023) · Rheumatology and Immunology Research · doi:10.2478/rir-2023-0019 · Cited by 14
He, B., Zhang, N., Jia, Y., Sun, Q., & Zhao, R. (2016) · Steroids · doi:10.1016/j.steroids.2016.08.004 · Cited by 11
“Gestational exposure to low-dose of dexamethasone (Dex, a synthetic GCs that is little metabolized by 11β-hydroxysteroid dehydrogenase 2) led to reduction of placental weight and retardation of fetal growth in several species including sheep [7], rodents [8, 9] and humans [10, 11].”
BackgroundOhyama, A., Tsuboi, H., Noma, H., Terasaki, M., Shimizu, M., Toko, H., Honda, F., Yagishita, M., Takahashi, H., Asashima, H., et al. (2018) · Modern Rheumatology · doi:10.1080/14397595.2018.1452352 · Cited by 8
“The use of CS was also reported as a predictor for APOs in previous studies [23] and Nugent and colleagues have reported that chronic exposure to CS alters expression of several vasoactive factors that might contribute to increased vascular resistance in the fetoplacental circulation [24].”
ResultZha, X., Fang, M., Zhong, W., Chen, L., Feng, H., Zhang, M., Wang, H., & Zhang, Y. (2024) · Toxicology Letters · doi:10.1016/j.toxlet.2024.11.005 · Cited by 7
Nizard, J. (2013) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2013.09.022 · Cited by 12
Maternal and umbilical cord copeptin levels in pregnancies complicated by fetal growth restriction
Bülbül, G. A., Kumru, S., Erol, O. Ö., İsenlik, B. S., Özdemir, Ö., Çağlar, M., Yılmaz, M., Kalaycı, M. Z., & Aydın, S. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.951622 · Cited by 6
“Likewise, an increase in the level of cortisol transfer to the fetus has long been suggested to be a potential pathogenic pathway triggering FGR [18].”
BackgroundIntraspinal cavernous bleeding during early pregnancy
Pars, K., Garde, N., Conzen, J., Pul, R., Dengler, R., Stangel, M., Skripuletz, T., & Trebst, C. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8245-6 · Cited by 5
Uteroplacental microvascular remodeling in health and disease
Li, R., Ma, L., Geng, Y., Chen, X., Zhu, J., Zhu, H., & Wang, D. (2025) · Acta Physiologica · doi:10.1111/apha.70035 · Cited by 5
“This led to changes associated with degeneration and dystrophy, exacerbating the progression of chronic placental insufficiency and FGR. 155 In summary, placental insufficiency occurs when the placenta fails to deliver sufficient nutrients and oxygen to the developing foetus, frequently leading to FGR and other compli…”
InfluentialThe Application Value of Three-Dimensional Power Doppler Ultrasound in Fetal Growth Restriction
Wang, Y., Liang, L., Liu, Y., Li, P., & Ren, J. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4087406 · Cited by 4
“Specifically, abnormalities of the villi vessels in the placenta initiates the remodeling compensatory response of the vascular wall, increasing the content of collagen and elastin and reinforcing the hardness of the blood vessels, which results in the increase of placental vascular resistance and reduction of the pla…”
BackgroundRetractedZhong, W., Chen, Y., Zha, X., Fang, M., Feng, H., Zhang, M., & Wang, H. (2025) · Placenta · doi:10.1016/j.placenta.2025.06.022 · Cited by 3
An update on the role of prokineticins in human reproduction-potential therapeutic implications
Kaur, K. K., Allahbadia, G. N., & Singh, M. (2013) · Open Journal of Genetics · doi:10.4236/ojgen.2013.33023 · Cited by 2
“Chronic glucocorticoid (GC) exposure potentiates placental chorionic plate artery constriction, leading to aberrant fetoplacental vascular resistance in fetal growth restriction with PROK1 being one of vasoactive factors altered by chronic GC [54].”
BackgroundPrediction of outcome in fetal autoimmune complete heart block
Sethi, N., Krishnan, A. N., & Donofrio, M. T. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5637 · Cited by 2
“The chronic use of transplacental dexamethasone is also associated with fetal growth restriction and increased placental resistance and may have also contributed to our findings.(19) Maternal lupus is a known precipitant for placental decidual thrombosis and vasculopathy.”
Effects of prenatal stress on reproductive function of male offspring through the KISS1 system
Gong, J., Lv, Y., Meng, Y., Zhang, W., Jiang, X., & Xiao, M. (2024) · Endocrine Connections · doi:10.1530/ec-24-0027 · Cited by 3
“…studies collectively show that intrauterine glucocorticoid exposure due to antenatal stress is strongly associated with low birth weight [26-28] and that prolonged exposure to high levels of glucocorticoids leads to increased vascular [29], inducing intrauterine growth restriction (IUGR) [30].”
Wyszynski, D. F. (2026) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-026-00555-x · Cited by 1
“They are key mediators of vascular resistance in the systemic circulation and thus may influence vascular resistance in the placenta and exert an effect on fetal growth [49].”
Michael, N., Sadananthan, S. A., Yuan, W. L., Ong, Y. Y., Loy, S. L., Huang, J. Y., Tint, M., Padmapriya, N., Choo, J. T. L., Ling, L. H., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003241 · Cited by 1
“High foetoplacental vascular resistance reflects increased impedance to blood flow in the umbilical artery and can result from impaired placental villous development or chronic exposure to elevated glucocorticoids [26,48].”
BackgroundEvaluation of Progesterone Effects on Fetal Doppler Velocimetry
Borna, S., Borna, H., Gotbizadeh, F., & Jalaldeh, M. J. (2016) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.17795/ojcr-9399 · Cited by 1
“The likely causes of this elevated vasoconstriction include defective trophoblast invasion and reduced endothelial nitric oxide (NO) (3, 8, 9).”
BackgroundLi, R., & DeMayo, F. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64635-4 · Cited by 2
[Diagnosis of a sudden loss of vision (without redness nor eye pain)].
Buisseret, D., & Cordonnier, M. (2014) · PubMed
王, 朝. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.143780
Li, R., & DeMayo, F. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21477-6.00392-8
Zhou, J., Zhang, S., Teng, Y., Lu, J., Guo, Y., Yan, S., Tao, F., & Huang, K. (2023) · Figshare · doi:10.6084/m9.figshare.23208021
Managing Reproductive Issues in Systemic Lupus Erythematosus
Zhao, J., & Zhang, X. (2026) · Springer eBooks · doi:10.1007/978-981-95-9581-5_7
Metadata
- Authors
- Nugent, J. L., Wareing, M., Palin, V., Sibley, C. P., Baker, P. N., Ray, D. W., Farrow, S. N., & Jones, R. L.
- Affiliations
- University of Manchester (GB)
- Maternal and Fetal Health Research Centre (J.L.N., M.W., V.P., C.P.S., R.L.J.)
- University of Auckland (NZ)
- Manchester Academic Health Science Centre (GB)
- Corresponding author
- Jones, R. L.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2013-01-07
- Volume
- 154
- Issue
- 2
- Pages
- 876-887
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2008362733
- Cited by
- 33
- References
- 50
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 4
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- GlaxoSmithKline
- Action Medical Research
- National Institute for Health and Care Research
- Manchester Biomedical Research Centre
- Medical Research Council
- Engineering and Physical Sciences Research Council (EP/I037253/1)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- fetal growth restriction, glucocorticoids, glucocorticoid receptor, 11β-hydroxysteroid dehydrogenase type 2, endothelial nitric oxide synthase, mifepristone, thromboxane receptor, bradykinin receptors, prokineticin 1, cyclooxygenase-2
- MeSH terms
- Arteries, Carbenoxolone, Chorion, Dexamethasone, Female, Fetal Growth Retardation, Glucocorticoids, Humans, Hydrocortisone, Placenta, Pregnancy, Vasoconstriction, Vasodilation, Mifepristone, 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid, Placental Circulation, 11-beta-Hydroxysteroid Dehydrogenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.